Global Health Career Week, in collaboration with the School of Public Health, concluded with a Q&A panel on protecting public health during the COVID-19 pandemic. This live Zoom event provided participants with an opportunity to ask questions to our panel of experts.  

The benefits of hydroxychloroquine being investigated in multi-site clinical trial launching in April

Researchers are investigating whether hydroxychloroquine – a commonly used anti-malarial and autoimmune drug – can prevent COVID-19.

A multi-site clinical trial, led by the University of Washington Department of Global Health/International Clinical Research Center (ICRC)  in collaboration with NYU Grossman School of Medicine, aims to definitively determine whether hydroxychloroquine can prevent transmission in people exposed to the virus.

In parts of Africa, where the rate of HIV is high, researchers found that using mobile vans to dispense antiretroviral treatment and other care greatly increased viral suppression.

Researchers enrolled 1,315 people living with HIV and not on antiretroviral treatment in a nearly three-year study in South Africa and Uganda using mobile vans to dispense treatment.

A new UW study led by Ruanne Barnabas, Associate Professor, UW Department of Global Health/ International Clinical Research Center (ICRC), aims to shed light on effective strategies for cervical cancer elimination. The study will increase understanding of how a combination of screening and vaccination strategies can be used more effectively to eliminate cervical cancer in low- and middle-income countries (LMICs).